| 146015 |
United Kingdom |
UK NEQAS for Leucocyte Immunophenotyping
UK NEQAS for Leucocyte Immunophenotyping
|
BCR::ABL1 and AML Translocation Identification
BCR::ABL1 and AML Translocation Identification
|
2024-05-03 |
|
|
| ID des Anbieters |
(120044) |
|
| 146032 |
United Kingdom |
UK NEQAS for Leucocyte Immunophenotyping
UK NEQAS for Leucocyte Immunophenotyping
|
Post-Stem Cell Transplant Chimerism Monitoring
Post-Stem Cell Transplant Chimerism Monitoring
|
2018-08-23 |
|
|
| ID des Anbieters |
(120044) |
|
| 146010 |
United Kingdom |
UK NEQAS for Leucocyte Immunophenotyping
UK NEQAS for Leucocyte Immunophenotyping
|
Paediatric Acute Leukaemia Translocations
Paediatric Acute Leukaemia Translocations
|
2024-05-17 |
|
|
| ID des Anbieters |
(120044) |
|
| 146022 |
United Kingdom |
UK NEQAS for Leucocyte Immunophenotyping
UK NEQAS for Leucocyte Immunophenotyping
|
BCR::ABL1 Major Quantification
BCR::ABL1 Major Quantification
|
2024-05-17 |
|
|
| ID des Anbieters |
(120044) |
|
| 146027 |
United Kingdom |
UK NEQAS for Leucocyte Immunophenotyping
UK NEQAS for Leucocyte Immunophenotyping
|
BRAF p.Val600Glu (V600E) Mutation Status for Hairy Cell Leukaemia
BRAF p.Val600Glu (V600E) Mutation Status for Hairy Cell Leukaemia
|
2018-08-23 |
|
|
| ID des Anbieters |
(120044) |
|
| 146052 |
United Kingdom |
UK NEQAS for Leucocyte Immunophenotyping
UK NEQAS for Leucocyte Immunophenotyping
|
BCR::ABL1 Kinase Domain Variant (Mutation) Status
BCR::ABL1 Kinase Domain Variant (Mutation) Status
|
2024-04-19 |
|
|
| ID des Anbieters |
(120044) |
|
| 146042 |
United Kingdom |
UK NEQAS for Leucocyte Immunophenotyping
UK NEQAS for Leucocyte Immunophenotyping
|
IG/TCR Clonality Status
IG/TCR Clonality Status
|
2024-05-17 |
|
|
| ID des Anbieters |
(120044) |
|
| 146037 |
United Kingdom |
UK NEQAS for Leucocyte Immunophenotyping
UK NEQAS for Leucocyte Immunophenotyping
|
FLT3 Mutation Status
FLT3 Mutation Status
|
2024-05-17 |
|
|
| ID des Anbieters |
(120044) |
|
| 146057 |
United Kingdom |
UK NEQAS for Leucocyte Immunophenotyping
UK NEQAS for Leucocyte Immunophenotyping
|
KIT p.Asp816Val (D816V) Mutation Status for Mast cell disease
KIT p.Asp816Val (D816V) Mutation Status for Mast cell disease
|
2024-04-19 |
|
|
| ID des Anbieters |
(120044) |
|
| 146067 |
United Kingdom |
UK NEQAS for Leucocyte Immunophenotyping
UK NEQAS for Leucocyte Immunophenotyping
|
NPM1 Mutation Status
NPM1 Mutation Status
|
2024-05-14 |
|
|
| ID des Anbieters |
(120044) |
|
| 146062 |
United Kingdom |
UK NEQAS for Leucocyte Immunophenotyping
UK NEQAS for Leucocyte Immunophenotyping
|
BCR::ABL1 Minor Quantification
BCR::ABL1 Minor Quantification
|
2024-04-19 |
|
|
| ID des Anbieters |
(120044) |
|
| 287280 |
United Kingdom |
UK NEQAS for Leucocyte Immunophenotyping
UK NEQAS for Leucocyte Immunophenotyping
|
Measurable Residual Disease for AML by Flow Cytometry (not accredited)
[Measurable Residual Disease for AML by Flow Cytoemtry (not accredited)]
Measurable Residual Disease for AML by Flow Cytometry (not accredited)
[Measurable Residual Disease for AML by Flow Cytoemtry (not accredited)]
|
2022-02-11 |
|
|
| ID des Anbieters |
(120044) |
|
| 287270 |
United Kingdom |
UK NEQAS for Leucocyte Immunophenotyping
UK NEQAS for Leucocyte Immunophenotyping
|
Measurable Residual Disease for CLL by Flow Cytometry (not accredited)
Measurable Residual Disease for CLL by Flow Cytometry (not accredited)
|
2022-02-11 |
|
|
| ID des Anbieters |
(120044) |
|
| 288363 |
United Kingdom |
UK NEQAS for Leucocyte Immunophenotyping
UK NEQAS for Leucocyte Immunophenotyping
|
Immune Monitoring Alternative Technologies
Immune Monitoring Alternative Technologies
|
2018-08-23 |
|
|
| ID des Anbieters |
(120044) |
|
| 495789 |
United Kingdom |
UK NEQAS for Leucocyte Immunophenotyping
UK NEQAS for Leucocyte Immunophenotyping
|
Measurable Residual Disease for Plasma Cell Myeloma by Flow Cytometry (not accredited)
[Measurable Residual Disease for Plasma Cell Myeloma by Flow Cytometry (not accredited)]
Measurable Residual Disease for Plasma Cell Myeloma by Flow Cytometry (not accredited)
[Measurable Residual Disease for Plasma Cell Myeloma by Flow Cytometry (not accredited)]
|
2022-02-11 |
|
|
| ID des Anbieters |
(120044) |
|
| 495801 |
United Kingdom |
UK NEQAS for Leucocyte Immunophenotyping
UK NEQAS for Leucocyte Immunophenotyping
|
Cerebrospinal Fluid (CSF) Immunophenotyping
Cerebrospinal Fluid (CSF) Immunophenotyping
|
2018-08-23 |
|
|
| ID des Anbieters |
(120044) |
|
| 495795 |
United Kingdom |
UK NEQAS for Leucocyte Immunophenotyping
UK NEQAS for Leucocyte Immunophenotyping
|
Haematological Malignancy Bone Marrow Aspirate Assessment
Haematological Malignancy Bone Marrow Aspirate Assessment
|
2018-08-23 |
|
|
| ID des Anbieters |
(120044) |
|
| 497464 |
United Kingdom |
UK NEQAS for Leucocyte Immunophenotyping
UK NEQAS for Leucocyte Immunophenotyping
|
Myeloid Gene Panels (Not Accredited)
Myeloid Gene Panels (Not Accredited)
|
2024-04-19 |
|
|
| ID des Anbieters |
(120044) |
|
| 941730 |
United Kingdom |
UK NEQAS for Leucocyte Immunophenotyping
UK NEQAS for Leucocyte Immunophenotyping
|
Myeloproliferative Neoplasms Diagnostic Testing (partially accredited)
Myeloproliferative Neoplasms Diagnostic Testing (partially accredited)
|
2024-05-03 |
|
|
| ID des Anbieters |
(120044) |
|
| 941705 |
United Kingdom |
UK NEQAS for Leucocyte Immunophenotyping
UK NEQAS for Leucocyte Immunophenotyping
|
Measurable Residual Disease for AML by Molecular Methods (not accredited)
Measurable Residual Disease for AML by Molecular Methods (not accredited)
|
2022-10-28 |
|
|
| ID des Anbieters |
(120044) |
|
